Search Results for keywords:"el-sfdd meetings"

Search Results: keywords:"el-sfdd meetings"

H. R. 1532 — To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.
💰
February 24, 2025
Status:Introduced in House
Congress:119
Words:2,057
H.R. 1532, known as the "Scientific EXPERT Act of 2025," aims to amend the Federal Food, Drug, and Cosmetic Act to facilitate drug development for rare diseases. It establishes a process for holding science-focused meetings led by external experts, involving medical professionals, drug...
Simple Explanation
The "Scientific EXPERT Act of 2025" is a new rule that helps doctors and scientists have meetings to talk about making new medicines for rare sicknesses, making sure they work safely, and getting them ready faster for people who need them.
S. 822 — To amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.
💰
March 03, 2025
Status:Introduced in Senate
Congress:119
Words:2,151
S. 822 is a legislative proposal aimed at amending the Federal Food, Drug, and Cosmetic Act to create science-focused meetings led by the Reagan-Udall Foundation. The purpose of these meetings is to bring together researchers, medical experts, drug sponsors, and patient...
Simple Explanation
This bill wants to create special meetings where smart people talk about making medicines for rare diseases, and it plans to use money each year to make sure these meetings happen. But some people are worried about how the money will be used and if it's fair to let only one group run these meetings.

Showing 1 to 2 of 2 results